Published: 24 August 2022
Committees
Agenda for the 191st meeting of the Medicines Adverse Reactions Committee to be held on Thursday 8 September 2022, at 9:00 am
1. |
MATTERS OF ADMINISTRATION |
|
1.1 |
Welcome and apologies |
|
1.2 |
Minutes and recommendations of the 190th MARC meeting |
|
1.3 |
Declarations of potential competing interests |
2. |
MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE |
| 2.1 | CARM quarterly report |
3. |
PHARMACOVIGILANCE REPORTS |
| 3.1 | Matters referred to the MARC under section 36 of the Medicines Act 1981 |
|
3.1.1 None |
|
| 3.2 | Matters referred to the MARC by Medsafe |
| 3.2.1 Recent safety signals related to use of Janus kinase inhibitors | |
| 3.2.2 Cannabidiol and systemic mTOR and calcineurin inhibitors: potential drug-drug interaction | |
| 3.2.3 Quetiapine and gestational diabetes mellitus | |
| 3.2.4 Risk Management Plan for Zolgensma (omasemnogene abeparvovec) | |
4. |
MEDSAFE PHARMACOVIGILANCE ACTIVITIES |
|
4.1 |
Report on standing agenda items |
|
4.2 |
Medsafe pharmacovigilance activities |
|
4.3 |
Prescriber Update |
|
4.4 |
Quarterly summary of recent safety communications |
